Clinical Trials Logo

Post Polycythaemia Myelofibrosis (PPV MF) clinical trials

View clinical trials related to Post Polycythaemia Myelofibrosis (PPV MF).

Filter by:
  • None
  • Page 1

NCT ID: NCT01558739 Completed - Clinical trials for Primary Myelofibrosis (PMF)

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

MACS2030
Start date: May 2012
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of INC424 in patients with PMF, PPV MF, or PET-MF using a composite measure of either an objective endpoint (> 50% reduction in splenomegaly using palpitation at 48 weeks) and/or a subjective endpoint (>50% reduction in total symptom score at 48 weeks).